Shanghai Longwood Biopharmaceuticals Co., Ltd.

This study tests an oral medication called LW402 in 480 adults with moderate-to-severe atopic dermatitis (eczema). Participants will receive either the drug or a placebo for 16 weeks. The goal is to see if LW402 can significantly improve skin symptoms like redness, itching, and r…

This study tests an experimental tablet called LW402 in 180 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Participants will take one of three doses or a placebo daily for up to 52 weeks. The main goal is to see if the drug can help bring b…